Patent Litigation in Peptides & Proteins

10 cases on record

Cases on record: 10
Classification: C07K16/00 · C07K16/24 · C07K16/10 · C07K16/12 · C07K16/42 · C07K16/18 · A61K47/68 · C07K16/28 · C07K16/32 · C07K14/715 · C07K16/22 · C07K16/08 · C07K7/02 · A61K39/00 · A61K38/00 · A61K38/06 · A61K39/395 · A61K47/48 · B32B1/00 · C07K16/46 · C07K14/76 · A61K9/00 · A61K9/19 · A61K31/00 · A61K47/18 · C07K14/47 · A61K38/08 · C07K14/775 · C12N15/62 · C07K16/40 · C12N15/113
Courts involved: D. Mass. · Fed. Cir. · N.D. W. Va. · U.S. Supreme Court · D. Del.

Case no.	Parties	Court	Filed	Duration	Outcome
1:25-cv-13004	Harbour Antibodies, BV v. Leveragen, Inc.	D. Mass.	14 Oct 2025	36 d	Voluntary dismissal
24-2124	In re: BAC IP B.V. v. DERRICK BRENT, Acting Under Secretary of Commerce for Intellectual Property and Acting Director of the United States Patent and Trademark Office	Fed. Cir.	23 Jul 2024	378 d	Unpatentable
24-1870	In re: XENCOR, INC. v. DERRICK BRENT, Acting Under Secretary of Commerce for Intellectual Property and Acting Director of the United States Patent and Trademark Office	Fed. Cir.	28 May 2024	289 d	Unpatentable
24-1176	Daiichi Sankyo v. Seagen, Inc.	Fed. Cir.	21 Nov 2023	742 d	Case Reversed
23-1762	ImmunoGen, Inc. v. Katherine K. Vidal	Fed. Cir.	18 Apr 2023	688 d	Appeal Dismissed
1:23-cv-00033	Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.	N.D. W. Va.	6 Apr 2023	110 d	Consent Judgment
22-1896	Institut Pasteur v. Katherine K. Vidal	Fed. Cir.	13 Jun 2022	548 d	Unpatentable
22-1346	Theripion, Inc. v. Katherine K. Vidal	Fed. Cir.	7 Jan 2022	580 d	Vacated and Remanded
21-757	Amgen, Inc. v. Sanofi	U.S. Supreme Court	18 Nov 2021	546 d	Appeal Dismissed
1:20-cv-01524	Daiichi Sankyo v. Seagen, Inc.	D. Del.	13 Nov 2020	1971 d	Voluntary dismissal

Source: Patsnap Litigation Data. Cases classified under Peptides & Proteins. Run this in Eureka

About this summary. This page summarises the litigation records within the coverage and snapshot dates stated here. Counts describe records in that dataset and do not, by themselves, establish the conduct, litigation success or legal position of any person or organisation.

Docket data has limits. Records are drawn from a snapshot and may lag the live docket. Sealed filings, amended complaints, counterclaims and post-closure motions may not be reflected. Party names, attorney names and firm affiliations are reproduced as recorded and may contain omissions. Where a field is absent from the record, this page marks it as not recorded rather than inferring a value.

No characterisation of the parties or the outcome. This page reports what the record contains. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, that any settlement occurred, or that any party prevailed. The filing of a claim is not a court finding, and a docket marked “closed” does not by itself establish infringement, validity, settlement or a decision on the merits.

No FTO or validity opinion. Nothing on this page constitutes a freedom-to-operate, novelty, validity or infringement opinion. Any decision touching a live patent dispute should be verified independently and reviewed with qualified patent counsel.

Third-party names and marks. Party, attorney, judge and company names appear for identification only. Company names may be trademarks of their owners; their appearance does not, by itself, imply affiliation with or endorsement by Patsnap.

Corrections and privacy requests. To report an inaccurate record or attribution, use the “Report an incorrect record” link on this page. For requests concerning your personal information, including, where applicable, the rights to access, rectify, erase, restrict or object to processing, use the “Privacy request” link. We assess requests under applicable law. See our Privacy Policy for details of this processing.

Peptides & Proteins Patent litigation record

10 cases on record

Where the claim space is crowded